Heart failure (HF) cardiogenic shock (CS) remains a highly morbid condition with scarce data for utilization of temporary mechanical circulatory support. Consensus statements from major societies aid in improving recognition of patients at risk for the disease and standardizing approach to patient management. Given differences in pathophysiology of HF-CS compared with acute myocardial infarction-CS, dedicated research into the field is needed.